Search Results for:

Sort by: Relevance Date
91 - 105 of 146 Results

Health system check-up - Assessing endurance capabilities

To develop strategy, assess your organization across 5 high impact areas as a foundation of understanding the options that best position your organization for success.
Healthcare & Life Sciences Institute Thu, 30 Mar 2017 00:00:00 GMT

U.S. tax reform – Planning in uncertain times

Forward-thinking life sciences companies may want to consider the impact of potential tax reform on their supply chain, R&D and more.
Healthcare & Life Sciences Institute Thu, 30 Mar 2017 00:00:00 GMT

CIO Survey 2016: Pharmaceutical sector findings

The Harvey Nash / KPMG CIO Survey is the largest IT leadership study in the world. Learn how pharmaceuticals companies responded on key topics in our pharmaceutical industry sector snapshot.
Healthcare & Life Sciences Institute Thu, 23 Mar 2017 00:00:00 GMT

Potential Tax Implications of Healthcare Reform

Healthcare reform legislation (if enacted) would near-certainly include significant tax law changes—changes that would affect individuals, the healthcare industry, and the business community at large.
Healthcare & Life Sciences Institute Fri, 03 Mar 2017 00:00:00 GMT

The ethical incentive program - Don’t let aggressive growth targets drive questionable sales tactics

As other sectors reel from government investigations in to incentive programs, life sciences board members are asking whether they, too, could be missing critical risks related to their organizations’ incentive programs. The answer may be yes.
Healthcare & Life Sciences Institute Mon, 03 Apr 2017 00:00:00 GMT

Scenario planning and uncertainty: Developing a dynamic strategy in a changing healthcare environment

Navigating this uncertain environment with confidence requires a dynamic strategy that adapts to a wide variety of future conditions.
Healthcare & Life Sciences Institute Thu, 16 Mar 2017 00:00:00 GMT

Transforming the life sciences supply chain: Cross-border transactions present unique opportunities to increase efficiency and meet global demand

Companies that use the moment of a cross-border deal to address supply chain position the function as a key driver of value and an enabler of change.
Healthcare & Life Sciences Institute Wed, 12 Apr 2017 00:00:00 GMT

2017 Serialization and traceability trends

How are pharmaceutical companies working to the November 2017 U.S. Drug Supply Chain Security Act (DSCSA) serialization requirements? This survey explores the industry’s current state of readiness to meet the 2017 DSCSA requirements and intentions to leverage associated value-added opportunities.
Healthcare & Life Sciences Institute Mon, 01 May 2017 00:00:00 GMT

Through the looking glass: A practical path to improving healthcare through transparency

Explore the results of our survey and learn more about what can be done to make transparency a powerful tool for improvement.
Healthcare & Life Sciences Institute Wed, 12 Apr 2017 00:00:00 GMT

Interoperability - The unfinished health IT agenda

Health IT systems and interoperability are critically important for optimizing performance and payment in the value-based healthcare environment. Indeed, as Vindell Washington, former National Coordinator for Health IT, and Andy Slavitt, former Acting Administrator of the Centers for Medicare...
Healthcare & Life Sciences Institute Mon, 15 May 2017 00:00:00 GMT

Partnering with patient groups - Develop mutually beneficial relationships between industry and patient representative bodies

Many life sciences firms are looking to patient groups to improve patient outcomes and inject true customer focus into their strategy.
Healthcare & Life Sciences Institute Tue, 04 Apr 2017 00:00:00 GMT

What’s News in Tax – Taxes and the American Health Care Act FAQs

On May 4, 2017, the U.S. House of Representatives passed the American Health Care Act of 2017 (the “AHCA”). This article explains the proposed legislation.
Healthcare & Life Sciences Institute Tue, 23 May 2017 00:00:00 GMT

Legislative update: House passes health care bill; includes tax provisions

The U.S. House of Representatives passed H.R. 1628, the American Health Care Act of 2017 (AHCA), by a vote of 217-212. A portion of the bill, which repeals and modifies a number of provisions of the Affordable Care Act, was previously reported by the Ways and Means Committee on a party-line...
Healthcare & Life Sciences Institute Fri, 05 May 2017 00:00:00 GMT

Medical Device Cybersecurity and Privacy: Medical Device "Frameworks and Standards"

Effective cybersecurity, privacy, and risk management are top priorities for medical device manufacturers (MDMs) and providers. However, some have struggled with where to start and to what extent to commit their finite resources.
Healthcare & Life Sciences Institute Tue, 16 May 2017 00:00:00 GMT

ACA reform focus: HHS final rule to stabilize the marketplace...Is it enough?

On April 13, HHS finalized its market stabilization rule, which aims to “stabilize the individual and small group markets and affirm the traditional role of State regulators.”
Healthcare & Life Sciences Institute Wed, 21 Jun 2017 00:00:00 GMT
91 - 105 of 146 Results: